#578 Engineering Longevity: Dr. Bill Andrews on Telomeres, Genetics, and the Future of Aging
What if aging is not inevitable, but a solvable biological problem?
In this episode of The CTO Show with Mehmet, Mehmet sits down with Dr. Bill Andrews, a renowned molecular geneticist and pioneer in telomere research. Dr. Andrews has spent decades studying the mechanisms of aging and is known for leading discoveries around telomerase, the enzyme connected to cellular aging.
The conversation explores the biological root causes of aging, the role of telomeres in limiting human lifespan, and the scientific pursuit of extending human healthspan. Dr. Andrews also shares insights into the challenges of biotech innovation, the economics of pharmaceutical research, and why breakthroughs in longevity science often struggle to reach the public.
This episode bridges biology, technology, and the future of human health, offering a deep dive into one of the most fascinating scientific frontiers of our time.
⸻
About the Guest
Dr. Bill Andrews is a molecular biologist and geneticist recognized for his groundbreaking work in telomere and telomerase research. Over his career, he has contributed to the discovery and development of multiple biotechnology innovations, including therapies related to cancer and genetic diseases.
Dr. Andrews holds more than 50 patents in genetics and biotechnology and has dedicated his career to understanding the biological mechanisms of aging and developing solutions to extend healthy human lifespan.
He is the founder of Sierra Sciences, a biotechnology company focused on discovering ways to activate telomerase and address the root causes of aging.
https://www.linkedin.com/in/william-h-andrews-ceo-5455b45/
⸻
Key Takeaways
• Aging may be driven by the shortening of telomeres, protective caps at the ends of chromosomes.
• The Hayflick Limit suggests human cells can only divide a finite number of times.
• Telomerase is an enzyme that can extend telomeres, potentially slowing or reversing aspects of aging.
• Longevity research faces major challenges due to funding structures and biotech investment models.
• Many scientists believe extending healthspan, not just lifespan, should be the primary goal of longevity science.
• Advances in biotechnology could eventually transform aging from an inevitability into a treatable biological process.
⸻
What You Will Learn
• Why aging occurs from an evolutionary and genetic perspective
• How telomeres influence cellular aging and lifespan
• The role of telomerase in longevity research
• Why curing aging is scientifically complex and financially challenging
• The relationship between aging and diseases such as cancer and Alzheimer’s
• How biotech innovation may shape the future of human longevity
⸻
Episode Highlights
00:00 Introduction to Dr. Bill Andrews and longevity research
02:00 Why humans age from an evolutionary perspective
06:30 Healthspan vs lifespan and the goals of longevity science
10:00 The Hayflick Limit and the biological clock of cells
13:30 Discovering telomeres and telomerase
18:00 The search for molecules that activate telomerase
22:00 How scientists measure aging and longevity
27:00 Why curing aging is scientifically and financially difficult
34:00 The role of pharmaceutical companies and research incentives
41:00 The economics of biotech innovation
48:00 Longevity research in animals and pets
55:00 The broader vision for curing aging
⸻
Resources Mentioned
• Sierra Sciences: https://sierrasci.com/
• Up One Podcast: https://podcasts.apple.com/us/podcast/up-one/id1815282315?ls=1
